In this study we describe the potential use of RSP extract to prevent neuronal dysfunction and neurodegeneration in vivo using transgenic C. elegans strains expressing mutant ATXN3, α-synuclein and tyrosine hydroxylase to mimic MJD and PD pathogenesis, respectively. This evidence concerns the gene SNCA and Spinocerebellar ataxia type 3.